A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer.

Front Oncol · 2022 · PMC9660259 · PMID 36387109

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In most of the trials discussed above, patients with higher PD-L1 expression showed a trend toward better survival following treatment with immune checkpoint inhibitors.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.